Quadrant Capital Group’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-585	Closed	-$8.76K	–	2757
2022 Q4	$8.76K	Buy	585 +364	+165%	+$5.45K	﹤0.01%	2020
2022 Q3	$3K	Buy	+221	New	+$3K	﹤0.01%	2280